Centinel Spine

11/12/2025

Don’t miss the opportunity to hear Armen Khachatryan, MD review the IDE study outcomes & significance of our recent 2-level FDA approval for prodisc C Vivo & SK.

Join Us:
NASS Evening Reception | 11/14 @ 6-7:30pm | Ruth’s Chris Steakhouse, Denver

For more:
https://nass2025.centinelspine.com

11/06/2025

You’re Invited | Nov 14 @ 6-7:30pm | Ruth’s Chris Steakhouse, Denver, CO

Join your peers & Armen Khachatryan, MD to celebrate and learn more about the details of our recent 2-level FDA-approval for & .

Learn more:
https://nass2025.centinelspine.com

11/04/2025

We were honored to host a surgeon-led educational course and bioskills lab in Las Vegas, bringing together leaders in spine surgery to exchange techniques, insights, and clinical experiences.

Our expert faculty presented treatment strategies for spinal disease, shared techniques and pearls for total disc replacement, and reviewed best practices through real-world case discussions.

A sincere thank you to our distinguished faculty: John Hall, MD, Michael Hisey, MD, Jason Garber, MD, Patrick Hill, MD, Grant D.Shifflett, MD, and Daniel Wesche, MD, for sharing their time and expertise.

To learn more about future MedEd courses, go to https://www.centinelspinemed.com

10/31/2025

10/30/2025

𝗛𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗧𝗼𝗻𝗶𝗴𝗵𝘁!
Live Webinar with Jack Zigler, MD October 30 | 8:00 PM ET

Don’t miss tonight’s webinar with Jack Zigler, MD, as he shares lessons from 25 years of experience with lumbar total disc replacement (TDR) using prodisc® L.

Dr. Zigler will cover what matters most: patient selection and indications for successful outcomes in lumbar TDR.

There’s still time to join us live!

Register now: https://cvent.me/gAY4ww

10/28/2025

In Q3 2025, Centinel Spine achieved record worldwide (WW) quarterly revenue for the prodisc® cervical total disc replacement (TDR) portfolio, in addition to exceeding $32 million in WW prodisc TDR revenue—a 42% year-over-year increase. With the recent 2-level FDA-approval for prodisc C Vivo & prodisc C SK, the Company expects robust revenue growth to continue through the fourth quarter.

Read more at:
https://centinelspine.press/2025/10/28/centinel-spine-grows-prodisc-total-disc-replacement-42-worldwide-in-third-quarter-2025-with-record-ebitda-results/

10/22/2025

𝟮𝟱 𝗬𝗲𝗮𝗿𝘀 𝗼𝗳 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲. 𝗢𝗻𝗲 𝗘𝘅𝗽𝗲𝗿𝘁 𝗣𝗲𝗿𝘀𝗽𝗲𝗰𝘁𝗶𝘃𝗲.
October 30 | 8:00 PM ETJoin Jack Zigler, MD, for an exclusive webinar as he reflects on over 25 years of clinical experience with lumbar total disc replacement (TDR) using prodisc® L.

Gain valuable insights into patient selection and surgical indications—the key elements to long-term success in lumbar TDR. Whether you're building your practice or refining your approach, don’t miss this opportunity to learn from one of the preeminent leaders in the field.

Secure your spot:
https://cvent.me/gAY4ww

10/21/2025

Your spine patients often want more than clinical expertise. They desire real stories from people who’ve lived through spine surgery and recovery. That’s why we’ve partnered with former spine-pain patients to create a community to share their stories at https://rediscovermylife.org.

Support your patients beyond the OR—send them to:
https://rediscovermylife.org/community.php

10/17/2025

A recent blog post on Centinel Spine’s rediscover Reads spine patient education blog provided a number of helpful tips for individuals to protect their necks and backs when using laptops, tablets, or phones.

Read more at: https://www.rediscovermylife.org/reads.php?p=47

10/14/2025

NEXT LEVEL CERVICAL TOTAL DISC REPLACEMENT:

prodisc C Vivo & prodisc C SK are Now FDA-Approved for 2-LEVEL USE!

A landmark IDE Clinical Study featuring prodisc C Vivo & prodisc C SK demonstrated the safety and clinical effectiveness of matching the disc to each individual spinal level.*

Learn more at: 2LVL.centinelspine.com
* Refer to the Summary of Safety and Effectiveness Data at 2level.centinelspine.com